| Date |
Title |
Category |
|
| 21/05/2013 | Boehringer Ingelheim announces change to board of directors | Pharmaceutical Company Restructures | Read More |
| 15/05/2013 | Lilly appoints temporary chief executive officer | Pharmaceutical Company Restructures | Read More |
| 15/05/2013 | Hospira re-appoints former chief scientific officer | Pharmaceutical Company Restructures | Read More |
| 14/05/2013 | Novo Nordisk to expand Kalundborg production site | Pharmaceutical Company Restructures | Read More |
| 13/05/2013 | Norgine appoints global market access director | Pharmaceutical Company Restructures | Read More |
| 09/05/2013 | Takeda announces takeover of Inviragen | Pharmaceutical Company Restructures | Read More |
| 09/05/2013 | AstraZeneca appoints BioCity to develop Alderley Park site | Pharmaceutical Company Restructures | Read More |
| 03/05/2013 | Sanofi appoints new executive committee members | Pharmaceutical Company Restructures | Read More |
| 18/04/2013 | Celgene appoints new UK head of haematology | Pharmaceutical Company Restructures | Read More |
| 17/04/2013 | Merck Serono launches not-for-profit EspeRare Foundation | Pharmaceutical Company Restructures | Read More |
| 16/04/2013 | Hospira appoints new senior-vice president of operations | Pharmaceutical Company Restructures | Read More |
| 16/04/2013 | Astellas appoints new head of global pharmacovigilance | Pharmaceutical Company Restructures | Read More |
| 15/04/2013 | Eisai creates new chief clinical officer role | Pharmaceutical Company Restructures | Read More |
| 08/04/2013 | Bristol-Myers Squibb appoints new chief scientific officer | Pharmaceutical Company Restructures | Read More |
| 03/04/2013 | Leo Pharma names new UK divisional directors | Pharmaceutical Company Restructures | Read More |
| 26/03/2013 | Shire to acquire Sarcode Bioscience | Pharmaceutical Company Restructures | Read More |
| 26/03/2013 | AstraZeneca confirms settlement over patent infringement | Pharmaceutical Company Restructures | Read More |
| 25/03/2013 | Takeda announces company restructures | Pharmaceutical Company Restructures | Read More |
| 25/03/2013 | AstraZeneca appoints product strategy executive vice president | Pharmaceutical Company Restructures | Read More |
| 21/03/2013 | Ipsen and Inspiration complete sale of haemophilia assets | Pharmaceutical Company Restructures | Read More |
